The Kalamazoo, Mich.-based medical device maker yesterday announced that it had named Kevin Lobo to be president of the new unit, which is comprised of the company’s own neurovascular and spine divisions and the assetts from its recent $1.5 billion acquisition of Boston Scientific Corp.’s (NYSE:BSX) stroke-treatment business.
"Kevin’s record of delivering business results, his strong customer focus and his global leadership abilities are ideally suited for ensuring we capitalize on the many opportunities the neurotechnology and spine markets present our organization.," Stryker CEO Stephen MacMillan said in prepared remarks.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Teleflex drops medical OEM president
Teleflex Inc. (NYSE:TFX) opted eliminated its position of president of aerospace, commercial and medical OEM as after it sold off its marine business. The company on April 22 notified John Suddarth that his position had been eliminated. In connection with his termination of employment, Mr. Suddarth is entitled to receive severance compensation. The termination was part of Teleflex’s efforts to consolidate its executive management structure after the divestiture.
- Semprus taps medical device vet for strategic advisory role
Semprus BioSciences announced the company’s collaboration with medical device executive David McClellan as a strategic adviser to the company’s management, including CEO David Lucchino. McClellan will oversee the company’s sales, marketing and business development. He is a 26-year veteran of the medical device industry and prior to taking on his role with Semprus, McClellan served as president of Boston Scientific spin-off Navilyst Medical Inc., according to Semprus.
- Vanderbilt names Cleveland Clinic Innovations exec to head tech transfer
Vanderbilt University has hired an executive with Cleveland Clinic Innovations to lead its technology transfer efforts. Alan Bentley will start with Vanderbilt on June 1 and hold the new (and long) title of assistant vice chancellor of technology transfer and intellectual property development, according to a statement from Vanderbilt, located in Nashville, Tenn., writes MedCity News.
- Life Technologies taps Ora Hirsch Pescovitz to board
Life Technologies Corp. (NSDQ:LIFE) announced that its shareholders approved Dr. Ora Hirsch Pescovitz, executive VP for medical affairs and health system CEO at the University of Michigan, as a new member of its board.
- NeurogesX CEO Anthony DiTonno set to retire
NeurogesX, Inc. (NSDQ:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced that long time CEO Anthony DiTonno will retire by Dec. 31, 2011. The company’s board has initiated a formal executive search for a CEO.
- D.C. lobby firm hires Senator’s health care adviser
Cassidy & Associates added a senate staffer to its health care team. Jennifer Nardi, who most recently worked for Sen. Richard Burr (R-N.C.), is joining the firm to work on health care and veterans issues, the firm said in a prepared statement. Nardi has worked at the FDA and was a health care policy adviser to Burr, who is ranking member of the Senate Veterans Affairs Committee, The Hill reported.
- ArQule appoints Dr. Susan Kelley to board
ArQule Inc. (NSDQ:ARQL) announced the appointment of Dr. Susan Kelley to its board. Kelley is currently an independent consultant to the pharmaceutical and biotechnology industries in the field of oncology drug development and strategy.
- Ximedica adds chief medical advisor
Ximedica announced the appointment of Dr. Emilio Belaval as chief medical advisor. In this role, Belaval will work with Ximedica to improve healthcare delivery workflow re-design to reduce complexity and increase patient safety. He will also serve as clinical expert for its medical device product development efforts.
- Valerie Palumbo joins PharmaNet as VP
PharmaNet Development Group Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced that Valerie Palumbo has joined the company as senior VP, corporate quality assurance.
- Minnesota health IT firm names new sales and business development exec
PenRad Technologies Inc., a Minnetonka, Minn.-based health IT company, announced that it has hired Dan Bickford as executive VP of sales and business development. Founded in 1995, PenRad’s web products aim to improve work flow, quality and revenue in image and information management in the healthcare sector, writes MedCity News.
- NxStage names Michael Miller president
NxStage Medical Inc. (NSDQ:NXTM), a manufacturer of innovative dialysis products, announced that Michael Miller, Jr., former senior VP and general manager of the Cardiac Care Business at Philips Healthcare, has joined the NxStage senior management team in the newly-created position of president, international.
- Advanced Cardiac Therapeutics names new director of sales and clinical affairs for Europe
Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, announced that Darren Spencer has joined the company as director of Sales and Clinical Affairs, Europe
- Menicon appoints Martin CFO for Europe
Menicon Co. Ltd. announced the appointment of Manuel Martin as CFO for Europe. Martin joins Menicon with over 15 years’ experience in finance covering diverse companies and sectors.